Fortrea Holdings Inc. (FTRE) Free Cash Flow
Fortrea Holdings Inc. (FTRE) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2023-12-31 | $128.10M |
| 2024-12-31 | $237.30M |
| 2025-12-31 | $88.30M |
How FTRE compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | $67.70M |
| TGTX | TG Therapeutics Inc. | -$24.99M |
| MYGN | Myriad Genetics Inc. | -$25.60M |
| CRVS | Corvus Pharmaceuticals Inc. | -$32.97M |
| TRVI | Trevi Therapeutics Inc. | -$42.10M |
These are five companies in the same sector as FTRE with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Fortrea Holdings Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("FTRE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FTRE | $18.53 | +1.42% | 0.60M |
| 3 | ||||
| 4 | ||||
| 5 |